The Leading eBooks Store Online
for Kindle Fire, Apple, Android, Nook, Kobo, PC, Mac, BlackBerry...
New to eBooks.com?Learn more
- Bestsellers - This Week
- Foreign Language Study
- Bestsellers - Last 6 months
- Graphic Books
- Health & Fitness
- Political Science
- Biography & Autobiography
- Psychology & Psychiatry
- Body Mind & Spirit
- House & Home
- Business & Economics
- Children's & Young Adult Fiction
- Juvenile Nonfiction
- Language Arts & Disciplines
- Crafts & Hobbies
- Science Fiction
- Current Events
- Literary Collections
- Literary Criticism
- Literary Fiction
- Social Science
- The Environment
- Sports & Recreation
- Family & Relationships
- Study Aids
- Folklore & Mythology
- Food and Wine
- Performing Arts
- True Crime
- Foreign Language Books
Most popular at the top
- Ashgate Publishing Ltd 2007; US$ 129.95
The author explores the pharmaceutical forecasting process; the varied tools and methods for new product and in-market forecasting; how they can be used to communicate market dynamics to the various stakeholders; and the strengths and weaknesses of differ more...
- Springer Fachmedien 2007; US$ 79.99
- Ashgate Publishing Ltd 2014; US$ 119.95
Blending the authors considerable experiences with those of interviewees and with their retrospective and forward-looking perspectives, this volume explains how to apply Knowledge Management in a variety of environments in order to achieve improved efficiency, better decision making and enhanced innovation. This is achieved by exploring Knowledge... more...
Weiterentwicklung gesundheitspolitischer Reformkonzepte und deren Auswirkungen auf GesundheitsdienstleisterBWV Berliner Wissenschafts-Verlag 2010; US$ 24.67
Hauptbeschreibung Eine Analyse der gesetzlichen Rahmenbedingungen und der zukünftigen Weiterentwicklung der Gesundheitssysteme ist unumgänglich, um das Potential für Effizienz- und Qualitätsgewinne und die gegenwärtigen und zukünftigen Wettbewerbsbedingungen von Unternehmen auf dem Gesundheitsmarkt auszuloten. Thesengeleitet wird in mehreren wissenschaftlichen... more...
- Diplomica Verlag 2010; US$ 35.95
Hauptbeschreibung The present piece of research deals with the use of Web 2.0 applications within the health care market. When reviewing literature it became evident that up to now, research which has been conducted in this field is rather limited to single aspects of the topic. Comprehensive research investigating the topic as a whole could not... more...
- Trine Day 2014; US$ 11.99
In the United States, cannabis is currently illegal, but this book investigates how big pharmaceutical companies are looking at an end-game of legality?controlled by them. It examines how the Amsterdam scene has been transformed; how home growers have been manipulated into using inferior techniques; and how companies, with help from the Drug Enforcement... more...
- John Blake Publishing 2009; US$ 8.74
It was one of the most brutal killing crusades that Britain has ever seen. Two cruel brothers and their henchmen, synonymous with robbery, torture and bribery, presided over a murderous reign so brutal that Nottingham became forth in the UK's gun crime league. This is just one of the shocking true stories contained in this chilling book.Having delved... more...
- Greystone Books 2008; US$ 22.95
In this hard-hitting indictment of the pharmaceutical industry, Ray Moynihan and Allan Cassels show how drug companies are systematically using their dominating influence in the world of medical science, drug companies are working to widen the very boundaries that define illness. Mild problems are redefined as serious illness, and common complaints... more...
- Emerald Group Publishing Limited 2005; US$ 199.00
Today, pharmaceutical companies are increasing their marketing budgets to advertise directly to the consumer. This spiraling effort has begun to attract the attention of both consumer advocacy groups, as well as the federal government (in the USA), in terms of taking a closer look at the effects of such advertising efforts. In July of 2005, the... more...
- Springer 2006; US$ 189.00
Deals with the topic of out-licensing as a novel form of risk-sharing collaborations. The phenomenon of out-licensing is illustrated by three major case studies of Novartis, Schering and Roche as well as several smaller case studies. This book applies the Nobel Prize awarded economic theory of Adverse Selection to analyze the topic theoretically. more...